Fang Qiu

The University of Texas at Dallas — United States

Medicine · Health Sciences

34h-index4.0kcitations217works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytomegalovirus and herpesvirus research(13), Photochemistry and Electron Transfer Studies(12), Head and Neck Cancer Studies(10), Cancer-related molecular mechanisms research(8), Protein Degradation and Inhibitors(8)

Publications217 total

Design, Synthesis, and Evaluation of Nucleolin-Bridged, MDM2-Recruiting IRAK4 Degraders for the Treatment of Autoimmune Diseases
Journal of Medicinal Chemistry·2026
The tumor microenvironment in leukemia: molecular pathways of immune evasion
Frontiers in Immunology·2026Open Access
Understanding the efficacy and efficiency of thermal infrared UAV for wildlife monitoring
Environmental Monitoring and Assessment·2026· 1 cited
Orbital-Selective Photoinduced Polaron Dynamics in Na <sub>2</sub> O <sub>2</sub> : Ultrafast Asymmetric Charge Transport Modulation in Sodium–Air Batteries
JACS Au·2025Open Access
Epigenetic‑ncRNA crosstalk in atherosclerosis: Mechanisms, disease progression and therapeutic potential (Review)
International Journal of Molecular Medicine·2025Open Access
Efficacy and Safety of Low-frequency Daratumumab in Systemic Light-chain Amyloidosis
Clinical Lymphoma Myeloma & Leukemia·2025
Characterization of lactic acid bacteria growth‐stimulating yeasts from pickled cucumber and evaluation of their impact on microbial community dynamics during cucumber fermentation
Journal of the Science of Food and Agriculture·2025· 1 cited
Targeting nucleolin facilitates the development of blood-tumor barrier-penetrating and glioblastoma-specific PROTACs
2025Open Access
Development of a chimeric monoclonal antibody as a potential diagnostic reference in PR3-ANCA detection
Journal of Immunological Methods·2025
Characterizing Thyroid Hormone Replacement, Baseline Thyrotropin, and Survival in Immune Checkpoint Inhibitor–Associated Thyroid Dysfunction
Thyroid·2025· 3 cited
[Efficacy and safety of programmed death receptor-1 inhibitor combined with albumin-bound paclitaxel and cisplatin in the neoadjuvant treatment of locally advanced head and neck squamous cell carcinoma].
PubMed·2025
Novel TROP2 antibody–drug conjugates for treatment of HER2-negative metastatic breast cancer patients with brain metastases: a promising option☆
ESMO Open·2025· 2 citedOpen Access
Abstract 5697: Targeting CBL and CBLB ubiquitin ligases to exhaust cancer stem cells in metastatic breast cancer
Cancer Research·2025
Penicinoid A, an undescribed sesterterpenoid with cytotoxic activity from <i>Penicillium herquei</i>
Natural Product Research·2025· 1 cited
Correction to “Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs”
Journal of the American Chemical Society·2025Open Access
A Pilot Randomized Controlled Trial Evaluating Peer Recovery Coaches for Addiction Recovery Among Indigenous Americans
Journal of the American Psychiatric Nurses Association·2025Open Access
Straightening trajectory of hooked fibers in the fiber transport channel of rotor spinning investigated by fluid solid coupled simulation
Scientific Reports·2025· 1 citedOpen Access
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
Frontiers in Medicine·2025· 1 citedOpen Access
Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients
Frontiers in Pharmacology·2025· 1 citedOpen Access
Engineered Chimeric Myeloperoxidase (Mpo) Antibodies as Candidate Multi-Platform Reference Materials for Mpo-Anca Detection
SSRN Electronic Journal·2025Open Access
page 1 of 11Next →

Frequent Co-authors

Diana F. Florescu(7), André C. Kalil(6), Ganglong Cui(6), Ling Guo(5), Iqbal Ahmad(4), Fang Yu(4), David F. Mercer(4), Hai-Qiang Mai(3), Ka-Jia Cao(3), Rui Sun(3), Qiu-Yan Chen(3), Pei‐Yu Huang(3), Dong-Hua Luo(3), Ming‐Yuan Chen(3), Ming‐Huang Hong(3), Rou Jiang(3), Sowmya Parameswaran(3), Sudha Balasubramanian(3), Wei‐Hai Fang(3), Alan N. Langnas(3)